Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 6 Pages: Pub: 2023 Mar 21 Epub: 2023 Mar 21 Authors De Oliveira FL , Salgaço MK , de Oliveira MT , Mesa V , Sartoratto A , Peregrino AM , Ramos WS , Sivieri K , |
|
|
Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Liu D , Li C , Cao T , Lv X , Yue Y , Li S , Cheng Y , Liu F , Huo G , Li B , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice. ✅
Go to Publication ✅
Journal of inflammation research (J Inflamm Res ) Vol: 16 Issue Pages: 1393-1404 Pub: 2023 Epub: 2023 Mar 27 Authors Fitri LE , Sardjono TW , Winaris N , Pawestri AR , Endharti AT , Norahmawati E , Handayani D , Kurniawan SN , Azizah S , Alifia LI , Asiyah R , Ayuningtyas TR , |
|
|
Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 22 Epub: 2022 Dec 22 Authors Shi S , Zhang Q , Sang Y , Ge S , Wang Q , Wang R , He J , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. ✅
Go to Publication ✅
Molecular carcinogenesis (Mol Carcinog ) Vol: 61 Issue 10 Pages: 941-957 Pub: 2022 Oct Epub: 2022 Jul 20 Authors Kumar R , Maurya AK , Parker KD , Kant R , Ibrahim H , Kabir MI , Kumar D , Weber AM , Agarwal R , Kuhn KA , Ryan EP , Raina K , |
|
|
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 18597 Pub: 2020 Oct 29 Epub: 2020 Oct 29 Authors Singh S , Bhatia R , Khare P , Sharma S , Rajarammohan S , Bishnoi M , Bhadada SK , Sharma SS , Kaur J , Kondepudi KK , |
|
|
Bifidobacterium longum subsp. longum Remodeled Roseburia and Phosphatidylserine Levels and Ameliorated Intestinal Disorders and liver Metabolic Abnormalities Induced by High-Fat Diet. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 16 Pages: 4632-4640 Pub: 2020 Apr 22 Epub: 2020 Apr 10 Authors Wu T , Sun M , Liu R , Sui W , Zhang J , Yin J , Fang S , Zhu J , Zhang M , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 22 Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Naghibi M , Pont-Beltran A , Lamelas A , Llobregat L , Martinez-Blanch JF , Rojas A , Álvarez B , López Plaza B , Arcos Castellanos L , Chenoll E , Vijayakumar V , Day R , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Bifidobacterium longumBL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 9 Pages: 6442-6460 Pub: 2024 Sep Epub: 2024 Jun 18 Authors Zhang X , Xu J , Dong X , Tang J , Xie Y , Yang J , Zou L , Wu L , Fan J , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
